×
About 3,478 results

ALLMedicine™ Subdural Hematoma Center

Research & Reviews  1,217 results

Development and validation of a recurrent prediction model for patients with unilateral...
https://doi.org/10.1016/j.clineuro.2023.107678
Clinical Neurology and Neurosurgery; Takei J, Inomata T et. al.

Mar 19th, 2023 - Approximately 10 % of patients with chronic subdural hematoma (CSDH) undergo reoperation after initial surgery. This study aimed to develop a predictive model for the recurrence of unilateral CSDH at initial surgery without hematoma volumetric ana...

Primary intracranial sarcoma masquerading as a chronic subdural haematoma: illustrative...
https://doi.org/10.1007/s00381-023-05919-y
Child's Nervous System : ChNS : Official Journal of the I... Vasoya P, Raj V et. al.

Mar 19th, 2023 - It is very unusual for a primary intracranial malignancy to present as a chronic subdural hematoma. This case report describes one such case in a 3-year-old girl who presented with raised intracranial pressure following a mild head injury. Imaging...

Impact of an early mobilization protocol on the reduction of medical complications afte...
https://doi.org/10.3171/2023.2.JNS222262
Journal of Neurosurgery; Sousa S, Pinto V et. al.

Mar 19th, 2023 - Timing of mobilization after chronic subdural hematoma (cSDH) surgery is highly heterogeneous among neurosurgical centers. Past studies have suggested that early mobilization may reduce medical complications without increasing recurrence, but evid...

Performance of a new portable near-infrared spectroscopy device for detection of trauma...
https://doi.org/10.1016/j.injury.2023.03.014
Injury Shukla D, Konar S et. al.

Mar 19th, 2023 - We report results of a newly developed portable near-infrared spectroscopy (NIRS) based point-of-care device CEREBO® to detect traumatic intracranial hematoma (TICH). Patients with alleged history of head injury visiting emergency room were enroll...

Middle Meningeal Artery Embolization Versus Conventional Management for Patients With C...
https://doi.org/10.1227/neu.0000000000002365
Neurosurgery Sattari SA, Yang W et. al.

Mar 18th, 2023 - The results from studies that compare middle meningeal artery (MMA) embolization vs conventional management for patients with chronic subdural hematoma are varied. To conduct a systematic review and meta-analysis on studies that compared MMA embol...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  84 results

Defining the Operating Characteristics of NIRS in the Diagnosis of Pediatric Traumatic Intracranial Hemorrhage
https://clinicaltrials.gov/ct2/show/NCT03905031

Mar 6th, 2023 - Patients that present to Dayton Children's Hospital with a head CT order for suspected TBI will be approached for enrollment. An alert will notify study personnel as CT scans are ordered. The goal is to obtain NIRS data within four-hours before or...

Patient Registry for Patients With Chronic Subdural Hematoma
https://clinicaltrials.gov/ct2/show/NCT04170582

Mar 2nd, 2023 - Chronic subdural hematoma (cSDH) is a frequent disease in- predominantly - elderly patients often caused by minor trauma to the bridging veins eventually leading to a collection of old blood in the subdural space over time. Besides age of the pati...

Exhaustive Drainage Versus Fixed-time Drainage for Chronic Subdural Hematoma After One-burr Hole Craniostomy
https://clinicaltrials.gov/ct2/show/NCT04573387

Feb 21st, 2023 - Chronic subdural hematomas (CSDHs) are one of the most common neurosurgical conditions. The goal of surgery is to alleviate symptoms and minimize the risk of symptomatic recurrences. The standard surgical technique includes burr-hole craniostomy, ...

The Use of Tranexamic Acid in the Treatment of Symptomatic Subdural Hematoma
https://clinicaltrials.gov/ct2/show/NCT05713630

Feb 17th, 2023 - Subdural hematoma (SDH) is a common condition experienced after head injury. Blood collects on the surface of the brain, causing headaches which can progress to confusion, weakness, or even coma. While patients with SDH often receive surgery, not ...

Association Between Dietary Factors and Chronic Subdural Hematoma (DISH)
https://clinicaltrials.gov/ct2/show/NCT05599217

Feb 8th, 2023 - Chronic subdural hematoma (CSDH) is one of the most common neurosurgical conditions, which is considered to be an inflammatory disease. Dietary factors can have an impact on the inflammatory mechanism in human body, which can increase a variety of...

see more →

News  84 results

New, Simple Technique for Chronic Subdural Hematoma Cuts Recurrence by 50%
https://www.medscape.com/viewarticle/984462

Nov 22nd, 2022 - Using irrigation warmed to body temperature during burr hole evacuation for chronic subdural hematoma (cSDH) cuts the risk for recurrence by more than half compared and should become the standard of care, new research suggests. Results from the mu...

BCMA and CD3 T-cell–Engaging Bispecific Antibody Shows Promise in R/R Multiple Myeloma
https://www.onclive.com/view/bcma-and-cd3-t-cell-engaging-bispecific-antibody-shows-promise-in-r-r-multiple-myeloma

Nov 1st, 2022 - ABBV-383 was effective and well tolerated at all administered doses in patients with relapsed/refractory multiple myeloma, according to safety and efficacy results from an ongoing first-in-human, phase 1 dose-escalation/-expansion study (NCT039337...

Cediranib Plus Olaparib Elicits rPFS Benefit in Metastatic Castration-Resistant Prostate Cancer
https://www.onclive.com/view/cediranib-plus-olaparib-elicits-rpfs-benefit-in-metastatic-castration-resistant-prostate-cancer

Oct 24th, 2022 - The combination of cediranib and olaparib (Lynparza) significantly improved radiographic progression-free survival (rPFS) compared with olaparib monotherapy in patients with metastatic castration-resistant prostate cancer (mCRPC), according to fin...

Bispecific Antibody ABBV-383 Looks to Fill Unmet Need in Heavily Pretreated Multiple Myeloma
https://www.onclive.com/view/bispecific-antibody-abbv-383-looks-to-fill-unmet-need-in-heavily-pretreated-multiple-myeloma

Aug 28th, 2022 - Promising safety and efficacy results were observed with the novel bispecific antibody ABBV-383 in patients with heavily pretreated relapsed or refractory multiple myeloma, according to updated results from a phase 1 trial (NCT03933735) presented ...

Helping patients move forward following traumatic brain injury
https://www.mdedge.com/familymedicine/article/255453/preventive-care/helping-patients-move-forward-following-traumatic
MDedge Family Medicine; Elizabeth A. Imbesi, PhD, ABPP

Jun 15th, 2022 - THE CASE Declan M*, a 42-year-old man, presents as a new patient for general medical care. One year ago, he sustained a severe frontal traumatic brain injury (TBI) when he was hit by a car while crossing a street.

see more →

Patient Education  3 results see all →